HAGE (DDX43) is a biomarker for poor prognosis and a predictor of chemotherapy response in breast cancer

Bibliographic Details
Main Authors:	Abdel-Fatah, T M A, McArdle, S E B, Johnson, C, Moseley, P M, Ball, G R, Pockley, A G, Ellis, I O, Rees, R C, Chan, S Y T
Format:	Online
Language:	English
Published:	Nature Publishing Group 2014
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4021517/

Similar Items